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Abstract 
The autosomal recessive form of distal renal tubular acidosis (dRTA), a condition associated with the 
systemic accumulation of acid owing to its reduced elimination through kidneys, is caused by 
ATP6V0A4 mutation, which is typically related to either late-onset sensorineural hearing loss (SNHL) or 
normal hearing. This article reports dRTA in seven year old boy, born to a Chinese couple who have 
family history of deafness. The patient does not have hearing impairment. ATP6V0A4 gene sequencing 
demonstrated that there were 2 heterozygous mutations, c.1376C>T and c.1029+5G>A, in gene 
ATP6V0A4. c.1376C > T (p.Ser459Phe) is a kind of missense mutation in gene ATP6V0A4. 
c.1029+5G>A is a kind of intragenic mutation near the cutting area of gene ATP6V0A4. ATP6V0A4 
gene mutation study substantiated the autosomal recessive dRTA without hearing impairment in the 
patient. This case report emphasizes the significance of early diagnosis and genetic screening of 
recessive forms of dRTA independent of hearing status and offer suitable intervention to treat dRTA as 
well as diminish the influence of SNHL on the child’s learning and communication in daily life. 
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Renal Tubular Acidosis (RTA) is a pathological 
state that is characterized by chronic acidosis 
owing to the excessive loss of bases from blood 
due to impaired reabsorption of bicarbonates or 
built up of acids in blood due to impaired 
excretion of hydrogen ions [1]. It leads to 
malfunctioning of various cells due to systemic 
electrolyte imbalance, in particular imbalance of 
chlorine, potassium, and calcium. There are two 
types of RTA, i.e., proximal RTA (pRTA) and 
distal RTA (dRTA) that are associated with 
proximal and distal renal tubules, respectively [2]. 
The impairment in distal acidification process 
could be due to the secretory defects (failure of 
distal H+ secretion; also known as primary, 
inherited, classic or rate-limiting defect) or non-
secretory defects (secondary defects with intact 
secretory mechanism). Secretory defect distal 
RTA is characterized by K+ secretion instead of 
H+ via apical membrane H+ ATPase or H+/K+ 
ATPase or the AE1 (HCO3-/Cl- exchanger) [3]. 
Two important types of primary dRTA are 
persistent and transient dRTA. An example of 
persistent dRTA is dRTA with sensorineural 
deafness [4]. Non-secretory defects include 
gradient, buffer, and voltage defect distal RTA. In 
gradient/back leak defect distal RTA, H+ 
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secretion is active; however, H+ are back-
diffused immediately after secretion. As 
compensation, loss of K+ takes place. It could be 
due to the abnormal membrane permeability. 
Buffer defect /low buffer type distal RTA also 
involves the loss of K+, since H+ secretion is 
impaired due to the increased luminal pH in the 
distal collecting tubule. Voltage defect distal RTA 
is characterized by hyperkalaemia due to the 
increased K+ reabsorption, and reduced H+ 
secretion [5,6]. 
 
Early-age dRTA is often inherited. It is commonly 
due to a defect in H+ ATPase or H+/K+ ATPase or 
the AE1 (HCO3-/Cl- exchanger) (Figure 1), which 
are found to be associated with the following two 
mutation and phenotypic patterns, i.e. autosomal 
dominant and sporadic/recessive dRTA. In 
autosomal dominant dRTA, defect in AE1 is due 
to the mutation in SLC4A1 gene on Ch 17. The 
features of this dRTA include hypokalemia, 
hypercalcemia and nephrocalcinosis, hereditary 
spherocytosis (HS), South-east Asian 
ovalocytosis (SAO), short stature and 
osteomalacia [7,8]. Autosomal Recessive dRTA 
is due to following defects: (i) H+ ATPase B1 
subunit defect (The gene responsible for this 
defect is ATP6B1 on Ch 2p13. These defects are 
accompanied with bilateral SNHL) [1]; (ii) H+ 
ATPase A4 subunit defect (The gene responsible 
for this defect is ATP6V0A4 on Ch7q33-34. 
These defects are accompanied with late onset 
of SNHL) [1]; and (iii) AE1 defect (The gene 
responsible for this defect is SLC4A1 on Ch 17. 
This defect is more prevalent in childhood and in 
Southeast Asians). Autosomal recessive distal 
RTA is accompanied with SNHL from early age 
[3]. 
 
Normal cochlear function depends on the 
homeostasis of cells and pH regulation [5]. The 
hearing impairment induced by the altered 
cellular homeostasis due to certain gene 
mutations has been reported [6]. These genes, in 
particular ATP6V0A4 gene, are involved in the 
production of certain protein complexes, such as 
vacuolar H+-ATPase (V-ATPase), which exist in 
the inner ear and nephrons. These complexes 
pump H+ across biomembranes and play a role 
in the regulation of cellular pH. Thus mutations in 
the ATP6V0A4 gene results in malfunctioning of 
the protein complex V-ATPase, eventually 
leading to pH disturbance in blood and cochlear 
fluid [7]. 
 
CASE REPORT  
 
A six year-old boy, born to a non-
consanguineous Chinese couple, was admitted 
to our hospital with complaints of polydipsia and 
polyuria, of two years duration. His birth record 
showed that the boy was born through eutocia 
(G2P2) after a full-term gestation, having a 
weight of 4 Kg with no emergency treatment at 
the time of birth. Afterwards, his growth and 
development was normal. 
 
However at the time of admission, physical 
examination revealed growth retardation (height, 
weight <P3), and his visual acuity was within 
normal limit. 
 
The supportive examinations showed alkaline 
urine, hypokalemia, elevated serum chloride, 
metabolic acidosis, and elevated alkaline 
phosphatase. Additionally, blood gas and 
electrolyte and close observation was regularly 
carried out. Double renal calcinosis could be 
identified in the B-mode ultrasound image. These 
findings revealed that the patient was suffering 
from renal tubular acidosis (I type). Urinary 
protein examination indicated moderate 
proteinuria, which is inconsistent with clinical 




          Figure 1: Types of dRTA 
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Combined with multiple renal cysts of both 
kidneys shown in B-mode ultrasound of the 
urinary tract, it was likely to be congenital kidney 
abnormalities, without excluding the possibility of 
genetic renal tubular lesions, which required 
complete genetic testing to confirm. Moreover, 
the enquiry of the patient’s family background 
revealed that his father, grandmother, and 
grandmother’s mother of the patient suffered 
from deafness, and all the three people did not 
suffer with eye or kidney diseases (Figure 2). 
Genetic examination of renal tubule was 
scheduled to confirm the diagnosis it revealed. 
 
Initially, informed consent was taken from the 
patient’s parents. Then DNA was extracted from 
the peripheral blood of the patient. Gene 
sequencing revealed 2 heterozygous mutations, 
c.1376C>T and c.1029+5G>A in gene 
ATP6V0A4. c.1376C > T (p.Ser459Phe) is a kind 
of missense mutation in gene ATP6V0A4. This 
mutation causes the change in amino acid 
number 459 in the protein coded by gene 
ATP6V0A4, from serine to phenylalanine. This 
mutation is extremely rare, and it has not been 
found in genomic sequencing databases for 
normal population.  c.1029+5G>A is a kind of 
intragenic mutation near the cutting area of gene 
ATP6V0A4. This mutation is also extremely rare, 
and its frequency was 0.0023, 0.0023, and 
0.0028. Distal renal tubular acidosis, related to 
gene ATP6V0A4, is a kind of autosomal 
recessive inheritance, and homozygous or 
compound heterozygous mutations could cause 
this disease. So the c.1376C>T and 
c.1029+5G>A mutations in gene ATP6V0A4 may 
cause the compound heterozygote, and it may 
be related to the reason for the disease, and 
further judgment needs more detailed clinical 
information. It was further suggested that Sanger 
sequence verification about these c.1376C>T 
and c.1029+5G>A mutations in Proband and his 
parents’ samples should be conducted to confirm 
whether these 2 mutations lie on different alleles, 
which form the compound heterozygous 
relationship. Moreover, renal assessment should 
also be advised, since this mutation is suspected 




The description and confirmation of RTA as a 
disorder were reported in 1935 and 1946, 
respectively, followed by the assigning of this 
term to the disease in 1951 [1-8]. It has been 
established that RTA should be an acquired or 
inherited disorder. The acquired RTA is induced 
by certain drugs, such as anticonvulsants, e.g 
valproic acid, anti-retroviral drugs, and anticancer 
drugs. Hence, close monitoring through periodic 
assessments of renal function and hearing of 
patients taking these drugs is compulsory [1]. 
Moreover, the inherited variety of RTA occurs 
through an autosomal recessive or autosomal 
dominant gene. Thus, the genetic testing and 
counseling are important attempts for offering the 
suitable intervention to treat RTA as well as 
suppress its effect on the patient’s daily life [2]. 
However, a high index of suspicion is required for 
the diagnosis of DRTA especially in the absence 
of hearing impairment. 
 
There is an association between RTA and 
hearing impairment. The diagnostic results of 
RTA can be an indicator of impaired hearing, 
which progresses with time in RTA cases. Thus 
the audiological assessment of RTA patients 
should be undertaken at planned intervals [3]. A 
cohort study has reported the case of a person 
having ATP6V0A4 mutations showing the 
commencement of hearing loss in adulthood 
rather than during childhood [4]. 
 
 
Figure 2: Father, grandmother, and grandmother’s mother of the patient suffered from deafness, and all the 
three people did not suffer with Eye or Kidney diseases 
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Another study has reported that autosomal 
recessive dRTA develops in individuals with 
ATP6V0A4 mutations without emergence of 
hearing impairment [5]. The case study of 
another patient with normal hearing has been 
reported showing hyperchloremia, hypokalemia, 
nephrocalcinosis, and high urine pH in initial 
clinical diagnosis. Later on, genetic diagnosis 
revealed the ATP6V0A4 mutations that caused 




ATP6V0A4 gene mutation study substantiated 
the autosomal recessive dRTA without hearing 
impairment in our patient. This case report 
highlights the importance of the significance of 
early diagnosis and genetic screening of 
recessive forms of dRTA independent of hearing 
status and offer suitable intervention to treat 
dRTA as well as reduce the effect of deafness on 
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